碧桂園(02007.HK):呈請聆訊延期至2026年1月5日
格隆匯8月7日丨碧桂園(02007.HK)公告,公司宣佈,高等法院於2025年8月7日批準了公司、呈請人、協調委員會及專案小組就原定於2025年8月11日舉行的呈請聆訊提出的聯合延期申請。呈請聆訊現被延期至2026年1月5日。
公司亦欣然宣佈,呈請人已向高等法院表示擬支持建議重組,惟須獲得進一步條款及條件,方可作實。公司感謝債權人對公司所進行工作的持續支持及參與,並將繼續與債權人合作以推進建議重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.